跳至主要内容
临床试验/NCT02283398
NCT02283398撤回不适用

The CARE-TAVI Study: Cardioprotective Effect of Remote Ischemic Preconditioning in Patients Undergoing Transcatheter Aortic Valve Implantation

Institut für Pharmakologie und Präventive Medizin3 个研究点 分布在 1 个国家开始时间: 2014年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
3
主要终点
post-procedural myocardial injury, defined by the geometric mean (95% CI) of the area under the curve (AUC) for cTnT

研究概览

简要总结

We aim to investigate whether RIPC (remote ischemic preconditioning) is effective in the TAVI setting to reduce post-procedural myocardial damage and improve patient outcome. Accordingly, we aim to investigate whether RIPC can be introduced as an integral part of the TAVI procedure, in order to reduce post-procedural myocardial damage and potentially improve patient outcome.

详细描述

Transcatheter aortic valve implantation (TAVI) is associated to myocardial injury, defined as post-procedural cardiac troponin (cTn) elevation. Earlier experiences have shown that myocardial damage can be encountered in a percentage of patients that varies from 1.5% to 17%, depending on the access route (transfemoral and transapical, respectively). The degree of rise in cTn after TAVI emerged as an independent predictor of mortality.

Remote ischaemic preconditioning (RIPC) consists of brief episodes of ischaemia applied to remote organs or tissues and has shown to result in a significant reduction in postoperative troponin levels in cardiac and non-cardiac surgery patients. Lately, growing evidence suggests that post-procedural troponin decreases due to RIPC application protocols protocols and is associated with improved outcome.

The patients will be divided into two Groups. In Group 1, RIPS will be induced with three cycles of Inflation of a blood-pressure cuff on the left arm to 200 mmHg for 5 min., followed by 5 min. of reperfusion while the cuff is deflated. In controls (Group 2), the cuff will be placed around the left arm without being inflated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Indication for elective TAVI following Heart Team discussion
  • •Stable hemodynamic conditions without circulatory support or catecholamines

排除标准

  • •Myocardial infarction at least 3 months before enrollment
  • •Stroke/TIA at least 3 months before enrollment
  • •Severe chronic kidney disease (defined as a baseline serum creatinine of > 1.5 mg/dl or an estimated glomerular filtration rate (eGFR) of 60 ml/min/1.73 m2 )
  • •PCI at least 3 months before enrollment
  • •Abnormal (>99th percentile of laboratory cut-off) baseline values of biomarkers of myocardial ischemia (i.e. TnT, CK-MB)
  • •Abnormal NSE values at baseline (local laboratory cut-off values)

研究组 & 干预措施

with RIPC

Experimental

RIPC will be induced with three cycles of inflation of a blood-pressure cuff on the left arm to 200 mm Hg for 5 min, followed by 5 min of reperfusion while cuff deflated

干预措施: RIPC (Procedure)

without RIPC

Sham Comparator

the cuff will be placed around the left arm without being inflated

干预措施: without RIPC (Other)

结局指标

主要结局

post-procedural myocardial injury, defined by the geometric mean (95% CI) of the area under the curve (AUC) for cTnT

时间窗: 72 hours after intervention

Change in cardiac troponine T (cTnT)

次要结局

  • Post-procedural myocardial injury(72 hours after intervention)
  • Post-procedural acute kidney injury(72 hours after intervention)
  • Post-procedural brain injury(72 hours after intervention)
  • composite of major adverse cardiac and cerebrovascular events(discharge, at 30 days and at 1 year)

研究者

发起方
Institut für Pharmakologie und Präventive Medizin
申办方类型
Network
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验